BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

  June 4, 2025

   · 

  4 min read
• Press Releases

  Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection

  June 4, 2025

   · 

  4 min read
• Press Releases

  enGene Announces the Resignation of its Chief Medical Officer

  June 4, 2025

   · 

  3 min read
• Press Releases

  BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

  June 4, 2025

   · 

  3 min read
• Press Releases

  New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options

  June 4, 2025

   · 

  3 min read
• Press Releases

  QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

  June 4, 2025

   · 

  8 min read
• Press Releases

  Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025

  June 4, 2025

   · 

  2 min read
• Press Releases

  Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025

  June 4, 2025

   · 

  1 min read
• Press Releases

  KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025

  June 4, 2025

   · 

  1 min read
• Press Releases

  Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

  June 4, 2025

   · 

  6 min read